GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹32 Cr | ₹3.58 Cr | ₹1.90 Cr | ₹2.02 Cr | ₹2.50 Cr |
What is the latest Total Non-Current Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹3.58 Cr |
| Mar2023 | ₹1.90 Cr |
| Mar2022 | ₹2.02 Cr |
| Mar2021 | ₹2.50 Cr |
How is Total Non-Current Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | 804.72 | |
| Mar2024 | ₹3.58 Cr | 87.92 | |
| Mar2023 | ₹1.90 Cr | -5.84 | |
| Mar2022 | ₹2.02 Cr | -18.96 | |
| Mar2021 | ₹2.50 Cr | - | |
Compare Total Non-Current Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,023.2 Cr | -3.2% | -3.2% | 7.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -3.2% |
-3.2% |
7.4% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses